Midostaurin: a magic bullet that blocks mast cell expansion and activation.

P Valent; C Akin; K Hartmann; T I George; Karl Sotlar; B Peter; K V Gleixner; K Blatt; W R Sperr; P W Manley; O Hermine; H C Kluin-Nelemans; M Arock; H-P Horny; A Reiter; J Gotlib

doi:10.1093/annonc/mdx290

Midostaurin: a magic bullet that blocks mast cell expansion and activation.

P Valent, C Akin, K Hartmann, T I George, Karl Sotlar (Co-Autor/-in), B Peter, K V Gleixner, K Blatt, W R Sperr, P W Manley, O Hermine, H C Kluin-Nelemans, M Arock, H-P Horny, A Reiter, J Gotlib

Universitätsinstitut für Pathologie

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

55 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	2367-2376
Fachzeitschrift	ANNALS OF ONCOLOGY
Jahrgang	28
Ausgabenummer	10
DOIs	https://doi.org/10.1093/annonc/mdx290
Publikationsstatus	Veröffentlicht - 2017

Zugriff auf Dokument

10.1093/annonc/mdx290

Dieses zitieren

Valent, P., Akin, C., Hartmann, K., George, T. I., Sotlar, K., Peter, B., Gleixner, K. V., Blatt, K., Sperr, W. R., Manley, P. W., Hermine, O., Kluin-Nelemans, H. C., Arock, M., Horny, H.-P., Reiter, A., & Gotlib, J. (2017). Midostaurin: a magic bullet that blocks mast cell expansion and activation. ANNALS OF ONCOLOGY , 28(10), 2367-2376. https://doi.org/10.1093/annonc/mdx290

Valent, P ; Akin, C ; Hartmann, K et al. / Midostaurin: a magic bullet that blocks mast cell expansion and activation. in: ANNALS OF ONCOLOGY 2017 ; Jahrgang 28, Nr. 10. S. 2367-2376.

@article{addf08af92fb41749c35bf78f4cc070e,

title = "Midostaurin: a magic bullet that blocks mast cell expansion and activation.",

keywords = "ADVANCED SYSTEMIC MASTOCYTOSIS, TYROSINE KINASE INHIBITORS, PROTOONCOGENE C-KIT, OF-THE-ART, PROTEIN-KINASE, DEPENDENT ACTIVATION, RESPONSE CRITERIA, MYELOID-LEUKEMIA, BLOOD BASOPHILS, IN-VITRO",

author = "P Valent and C Akin and K Hartmann and George, {T I} and Karl Sotlar and B Peter and Gleixner, {K V} and K Blatt and Sperr, {W R} and Manley, {P W} and O Hermine and Kluin-Nelemans, {H C} and M Arock and H-P Horny and A Reiter and J Gotlib",

note = "Sotlar: [ 6 ] Paracelsus Med Univ Salzburg, Inst Pathol, Salzburg, Austria",

year = "2017",

doi = "10.1093/annonc/mdx290",

language = "English",

volume = "28",

pages = "2367--2376",

journal = "ANNALS OF ONCOLOGY ",

issn = "0923-7534",

number = "10",

}

Valent, P, Akin, C, Hartmann, K, George, TI, Sotlar, K, Peter, B, Gleixner, KV, Blatt, K, Sperr, WR, Manley, PW, Hermine, O, Kluin-Nelemans, HC, Arock, M, Horny, H-P, Reiter, A & Gotlib, J 2017, 'Midostaurin: a magic bullet that blocks mast cell expansion and activation.', ANNALS OF ONCOLOGY , Jg. 28, Nr. 10, S. 2367-2376. https://doi.org/10.1093/annonc/mdx290

Midostaurin: a magic bullet that blocks mast cell expansion and activation. / Valent, P; Akin, C; Hartmann, K et al.
in: ANNALS OF ONCOLOGY , Jahrgang 28, Nr. 10, 2017, S. 2367-2376.

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

TY - JOUR

T1 - Midostaurin: a magic bullet that blocks mast cell expansion and activation.

AU - Valent, P

AU - Akin, C

AU - Hartmann, K

AU - George, T I

AU - Sotlar, Karl

AU - Peter, B

AU - Gleixner, K V

AU - Blatt, K

AU - Sperr, W R

AU - Manley, P W

AU - Hermine, O

AU - Kluin-Nelemans, H C

AU - Arock, M

AU - Horny, H-P

AU - Reiter, A

AU - Gotlib, J

N1 - Sotlar: [ 6 ] Paracelsus Med Univ Salzburg, Inst Pathol, Salzburg, Austria

PY - 2017

Y1 - 2017

KW - ADVANCED SYSTEMIC MASTOCYTOSIS

KW - TYROSINE KINASE INHIBITORS

KW - PROTOONCOGENE C-KIT

KW - OF-THE-ART

KW - PROTEIN-KINASE

KW - DEPENDENT ACTIVATION

KW - RESPONSE CRITERIA

KW - MYELOID-LEUKEMIA

KW - BLOOD BASOPHILS

KW - IN-VITRO

U2 - 10.1093/annonc/mdx290

DO - 10.1093/annonc/mdx290

M3 - Review article

C2 - 28945834

SN - 0923-7534

VL - 28

SP - 2367

EP - 2376

JO - ANNALS OF ONCOLOGY

JF - ANNALS OF ONCOLOGY

IS - 10

ER -

Valent P, Akin C, Hartmann K, George TI, Sotlar K, Peter B et al. Midostaurin: a magic bullet that blocks mast cell expansion and activation. ANNALS OF ONCOLOGY . 2017;28(10):2367-2376. doi: 10.1093/annonc/mdx290